Topic of Histopathology Blinding in Nonclinical Safety Biomarker Qualification Studies

被引：11

作者：

Burkhardt, John E. ^{[1
]}

Ennulat, Daniela ^{[2
]}

Pandher, Karamjeet ^{[3
]}

Solter, Phillip F. ^{[4
]}

Troth, Sean P. ^{[5
]}

Boyce, Rogely Waite ^{[6
]}

Zabka, Tanja S. ^{[7
]}

机构：

[1] Abbott Labs, Abbott Pk, IL 60064 USA

[2] GlaxoSmithKline Inc, King Of Prussia, PA USA

[3] Pfizer Inc, Groton, CT 06340 USA

[4] Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA

[5] Merck Sharp & Dohme Ltd, West Point, PA 19486 USA

[6] WIL Res Labs, Ashland, OH USA

[7] Roche Pharmaceut, Nutley, NJ USA

来源：

TOXICOLOGIC PATHOLOGY | 2010年 / 38卷 / 04期

关键词：

D O I：

10.1177/0192623310371221

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：666 / 667

页数：2

共 7 条

[1] Best practices guideline: T6oxicologic histopathology [J].

Crissman, JW ;

Goodman, DG ;

Hildebrandt, PK ;

Maronpot, RR ;

Prater, DA ;

Riley, JH ;

Seaman, WJ ;

Thake, DC .

TOXICOLOGIC PATHOLOGY, 2004, 32 (01) :126-131

[2]

Dodd DC., COMM TOXICOL, V1988, P81

[3]

Iatropoulos M J, 1984, Toxicol Pathol, V12, P305

[4]

Prasse K, 1986, Toxicol Appl Pharmacol, V83, P184, DOI 10.1016/0041-008X(86)90336-4

[5] TOXICITY TESTING - SOME PRINCIPLES AND SOME PITFALLS IN HISTOPATHOLOGICAL EVALUATION [J].

ROE, FJC .

HUMAN TOXICOLOGY, 1988, 7 (05) :405-410

[6] Bias in toxicology [J].

Wandall, Birgitte ;

Hansson, Sven Ove ;

Ruden, Christina .

ARCHIVES OF TOXICOLOGY, 2007, 81 (09) :605-617

[7]

Weinberger MA., 1979, TOXICOL PATHOL, V7, P14

← 1 →